bio:cap 2026
With bio:cap 2026, a new international event format is launched, bringing together health sciences and artificial intelligence on a single platform. The first edition will take place from June 9 to 11, 2026, at the CityCube Berlin.
bio:cap is an exclusive, carefully curated international platform at the intersection of Life Sciences (Biotech/Pharma), Artificial Intelligence, and capital. The event is designed as a strategic environment focused on generating concrete deals and fostering long-term collaborations and growth strategies. It combines an exhibition, a conference, and a curated networking network, bringing together stakeholders from biotechnology, pharmaceuticals, diagnostics, bioengineering, data, and AI, as well as investors, researchers, clusters, policymakers, and innovation ecosystems.
The goal is to efficiently facilitate relevant conversations and collaborations, and to accelerate innovation and commercialization in the pharmaceutical and biotechnology sectors through AI-driven advancements. To this end, bio:cap features a carefully curated program, relevant market and technology topics, high-visibility stage formats (panel discussions, talks, presentations), and structured matchmaking that deliberately connects the right stakeholders.
bio:cap is built together with top-tier founding partners such as Charité – Universitätsmedizin Berlin, Berlin Institute of Health (BIH), and Hasso Plattner Institute (HPI), and is supported by a high-level Steering Committee bringing together science, technology, venture capital, and industry.
It will bring together up to 3,000 selected participants from across Europe and other international markets, including:
- European and international VCs, CVCs, family offices, and strategic capital providers
- Pharma and diagnostics executives (CEO, BD, Innovation, R&D, AI transformation)
- Biotech, TechBio, and AI-based startups (Seed to Series B and beyond)
- Hospitals, academia, and research institutions, including translational and clinical stakeholders
- Public stakeholders in regulation, funding, and innovation policy (Germany/EU)
Conference programme: https://www.biocap-europe.com/en/program/speaker
AseBio members benefit from a 25% discount on registration from March 1 (investors, industry, scale-ups & start-ups) and a 10% discount on booth bookings (until March 31, 2026).